Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients

被引:94
作者
Gao, S. G. [1 ]
Li, K. H. [1 ]
Zeng, K. B. [1 ,2 ]
Tu, M. [1 ,3 ]
Xu, M. [1 ]
Lei, G. H. [1 ]
机构
[1] Cent S Univ, Xiangya Hosp, Dept Orthopaed, Changsha 410008, Hunan, Peoples R China
[2] Cent Hosp Xiangtan, Dept Spinal Surg, Xiangtan 411100, Hunan, Peoples R China
[3] Second People Hosp Jingmen, Dept Orthopaed, Jingmen 448000, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
Osteopontin; Osteoarthritis; Synovial fluid; Articular cartilage; CELL-SURVIVAL; MESSENGER-RNA; BONE; EXPRESSION; SERUM; CD44; CHONDROCYTES; MIGRATION; ADHESION; PROTEIN;
D O I
10.1016/j.joca.2009.07.009
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
100224 [整形外科学];
摘要
Objective: To investigate osteopontin (OPN) levels in both synovial fluid and articular cartilage of patients with primary knee osteoarthritis (OA) and their relationship with severity of the disease. Method: Fifty patients aged 48-81 years with knee OA and 10 healthy controls were enrolled in this study. Anteroposterior knee radiographs or/and Mankin score were taken to determine the disease severity of the affected knee. The radiographic grading of OA in the knee was performed by using the Kellgren-Lawrence criteria. OPN levels in synovial fluid were measured using enzyme-linked immunosorbent assay. OPN levels in articular cartilage were assessed by immunohistochemical methods. Results: Compared to healthy controls, OA patients had higher OPN concentration in synovial fluid (4519.60 +/- 1830.37, 95%CI 3999.42-5039.79 vs 1179.70 +/- 303.39, 95%CI 1035.53-1438.74 pg/ml, P < 0.001)and articular cartilage(0.6 +/- 0.06, 95%CI 0.59-0.62 vs 0.43 +/- 0.07, 95%CI 0.38-0.48, P < 0.01). In addition, synovial fluid OPN levels showed a positive correlation with articular cartilage OPN levels (r=0.411, 95%CI 0.150-0.619, P = 0.003). Subsequent analysis showed that synovial fluid OPN levels significantly correlated with severity of disease (Spearman's rho = 0.581, 95%CI 0.335-0.726, P < 0.001). Furthermore, the articular cartilage levels of OPN also correlated with disease severity (Spearman's rho = 0.675, 95%CI 0.500-0.808, P < 0.001). Conclusions: OPN in synovial fluid and articular cartilage is associated with progressive joint damage and is likely to be a useful biomarker for determining disease severity and progression in knee OA. Crown Copyright (C) 2009 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International. All rights reserved.
引用
收藏
页码:82 / 87
页数:6
相关论文
共 35 条
[11]
Osteopontin: a bridge between bone and the immune system [J].
Gravallese, EM .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (02) :147-149
[12]
Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis [J].
Kaneko, S ;
Satoh, T ;
Chiba, J ;
Ju, CY ;
Inoue, K ;
Kagawa, J .
CYTOKINES CELLULAR & MOLECULAR THERAPY, 2000, 6 (02) :71-79
[13]
RADIOLOGICAL ASSESSMENT OF OSTEO-ARTHROSIS [J].
KELLGREN, JH ;
LAWRENCE, JS .
ANNALS OF THE RHEUMATIC DISEASES, 1957, 16 (04) :494-502
[14]
Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions [J].
Kolb, A ;
Kleeff, J ;
Guweidhi, A ;
Esposito, I ;
Giese, NA ;
Adwan, H ;
Giese, T ;
Büchler, MW ;
Berger, MR ;
Friess, H .
CANCER BIOLOGY & THERAPY, 2005, 4 (07) :740-746
[15]
HIGH-RESOLUTION IMMUNOLOCALIZATION OF OSTEOPONTIN AND OSTEOCALCIN IN BONE AND CARTILAGE DURING ENDOCHONDRAL OSSIFICATION IN THE CHICKEN TIBIA [J].
MCKEE, MD ;
GLIMCHER, MJ ;
NANCI, A .
ANATOMICAL RECORD, 1992, 234 (04) :479-492
[16]
McKee MD, 1996, MICROSC RES TECHNIQ, V33, P141, DOI 10.1002/(SICI)1097-0029(19960201)33:2<141::AID-JEMT5>3.0.CO
[17]
2-W
[18]
Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks [J].
O'Regan, AW ;
Nan, GJ ;
Chupp, GL ;
Berman, JS .
IMMUNOLOGY TODAY, 2000, 21 (10) :475-478
[19]
Ohshima S, 2002, J RHEUMATOL, V29, P2061
[20]
Petrow PK, 2000, ARTHRITIS RHEUM, V43, P1597, DOI 10.1002/1529-0131(200007)43:7<1597::AID-ANR25>3.3.CO